Preparation of La Crosse virus hemagglutinating antigen in BHK-21 suspension cell cultures

Appl Microbiol. 1969 Sep;18(3):433-7. doi: 10.1128/am.18.3.433-437.1969.

Abstract

Hemagglutinating and complement-fixing antigens of La Crosse virus (California arbovirus group) were produced in serum-free suspension cultures of BHK-21/13S cells. The appearance and production of these antigens were correlated with the titer of infectious virus. No significant differences in antigen titers were produced by varying virus dose 10-fold. Hemagglutinin appeared 6 to 8 hr after inoculation and reached peak titer in 14 to 22 hr. Both beta-propiolactone and Tween 80-ether treatment inactivated infectious virus in the antigens. Unlyophilized antigen was stable at -60, 5 and 24 C for at least 117 days but not for 1 year. Lyophilized antigen was stable for at least a year, however, at -20 and 5 C. Cell culture-produced antigen was more sensitive than brain-produced antigen in detecting hemagglutination inhibition antibody in human sera.

MeSH terms

  • Animals
  • Antibody Formation
  • Antigens / biosynthesis*
  • Arboviruses / drug effects
  • Arboviruses / immunology*
  • Brain
  • Cell Line
  • Complement Fixation Tests
  • Cricetinae
  • Culture Media
  • Culture Techniques*
  • Drug Stability
  • Freeze Drying
  • Hemagglutination Inhibition Tests
  • Hemagglutination Tests
  • Hemagglutinins, Viral
  • Humans
  • Kidney
  • Lactones / pharmacology
  • Mice
  • Propionates / pharmacology
  • Surface-Active Agents / pharmacology

Substances

  • Antigens
  • Culture Media
  • Hemagglutinins, Viral
  • Lactones
  • Propionates
  • Surface-Active Agents